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INTRODUCTION 
Sustained release drug delivery systems are designed to 
achieve a prolonged therapeutic effect by continuously 
releasing medication over an extended period of time. The 
goal in designing oral sustained or controlled delivery 
systems is to reduce the frequency of the dosing or to 
increase effectiveness of the drug by localizing at the site 
of action, reducing the dose required or provide uniform 
drug delivery, thereby also improving patient compliance. 
Sustained release dosage forms provide a better control of 
plasma drug levels, less dosage frequency, less side effect, 
increased efficacy and constant delivery.1 
Enteric term refers to intestine.2 The most common type of 
modified release coating is the enteric coat, which is 
designed to prevent release of the drug substance in the 
stomach because the drug is either irritant to the gastric 
mucosa or it is unstable in gastric juice. Film coating can 
also be used to delay the release of drugs.
3 
Captopril is used therapeutically as an anti-hypertensive 
agent. Captopril is widely used for the arterial 
hypertension. It acts as a potent and specific inhibitor of 
angiotensin converting enzyme. It is used in the 
management of hypertension, in heart failure, following 
myocardial infarction and in diabetic nephropathy. It 
seems to be one of the most widely used drug for 
hypertension and heart problems.4 
In the present investigation, an attempt was made to 
decrease dosing frequency. Captopril is showing less 
bioavailability in presence of food. With enteric coating 
problem should be solved out. 
MATERIAL AND METHOD 
Captopril was purchased from wockhardt Ltd. 
Aurangabad. HPMC K4M, talc, lactose, magnesium 
stearate, di-sodium hydrogen orthophosphate and sodium 
chloride was purchased from Central drug house (P) LTD 
New Delhi. Sodium alginate was procured from himedia 
lab. Pvt Ltd. Mumbai. Eudragit RL 100 was purchased 
from balaji drugs, Gujarat. 
Extraction of polymer from Aegle marmelos
5
 
In this method, 250 gm edible fruits of Aegle marmelos 
were soaked in double distilled water and boiled for 5 hrs 
in a water bath until slurry was formed. The slurry was 
cooled and kept in refrigerator overnight so that most of 
the undissolved portion was settled out. The upper clear 
solution was decanted off and centrifuged at 500 rpm 20 
mins. The supernatant was concentrated at 600C on a water 
bath until the volume reduced to one third of its original 
volume. Solution was cooled down to the room 
temperature and was poured into thrice the volume of 
acetone by continuous starring. The precipitate was 
washed repeatedly with acetone and dried at 500C under 
vacuum. The dried material was powdered and kept in a 
desiccator. 
Physical characteristics of granules before 
compression
6
 
The angle of repose can be determined by fixed funnel 
method. The bulk density and tapped density were 
determined by the cylinder method.  
Compressibility index and hausner ratio was calculated by 
using following formula: 
Compressability index =   (Vo-Vf) *100 
                                                             Vo 
Hausner Ratio =  V0 
                                                            Vf 
   Were V0 =initial volume, Vf =tapped volume 
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Preparation of mucoadhesive tablet
7
 
Mucoadhesive tablets each containing 50 mg of captopril 
were prepared by conventional wet granulation method 
employing HPMC K4M, bael gum and chitosan as 
mucoadhesive materials as shown in the formulae given in 
table No. 1. A batch of 60 tablets was prepared in each 
case a blend of 3 gm of captopril with required amount of 
polymers. Which were then granulated along with a 
solvent blend of water and ethanol (1:1).  Firstly required 
amount of drug and polymer were taken in a mortar and 
pestle for the trituration. Then the solvent was added drop 
wise with continuous stirring until the wet mass was 
formed. Then the wet masses were passed through 12 
mesh sieve and wet granules were dried at 60º C for 4 hrs. 
The dried granules (20 mesh) after blending with talc (0.5 
%) and magnesium stearate (0.5 %) in a laboratory cube 
blender for 5 mins. Then granules were compressed into 
300 mg tablets of hardness 6-7 kg/cm2 on a tablet 
compression machine using 10 mm biconcave shaped 
punches. Prepared tablets were used for the evaluation 
parameters.
 
Table 1: Composition of the various formulations 
 
Coating procedure of mucoadhesive tablet
7 
Preparation of film coating solution 
A basic film coating solution as shown in table no. 2 was 
prepared. In a 500 ml clean beaker about 100 ml of 
methanol was measured and the required amount of 
polymer eudragit RL100 was added and allowed to soak 
overnight. Next day morning, filter solution through 
muslin cloth and kept under a stirrer for 5 mins to get a 
uniform dispersion of the polymer solution. Other 
ingredients such as plasticizers, opacifier, colour etc. 
were added by mixing to get the coating liquid. 
Table 2: Composition of coating solution 
S. No. Ingredients Amount 
1 Eudragit RL100 7.5% 
2 PEG 400 0.8% 
3 Titanium dioxide 3.1% 
4 Methanol 100 ml 
5 Colour 0.1% 
 
Coating procedure: 
Mucoadhesive tablets of captopril taken in a perforated 
tray. The coating solution was filled into the laboratory 
sprayer. Then the coating solution was sprayed over the 
tablets from certain distance by controlling the spray rate. 
Constant temperature was maintained, while the tray was 
shaken manually. The solution was sprayed intermittently 
allowing the solvent to evaporate.  
Evaluation of the mucoadhesive tablet: 
Thickness and diameter:
8
 
The thickness and diameter of mucoadhesive tablets was 
determined using vernier calliper. Ten individual tablets 
from each batch were used and the results averaged. 
Weight variation: 
Weight variation was performed for 20 tablets from each 
batch using an electronic balance and average values 
were calculated. 
Friability: 7 
The friability test was done using Roche’s friabilator. Ten 
tablets were selected and weighed individually. Then the 
friability test was carried out at 25 rpm for 4 mins. These 
tablets were then again weighed and percentage loss in 
weight was calculated. The friability (F) is given by the 
formula:     
                                 F= (1-Wo/W) 100 
Where Wo is weight of tablets before test and W is 
weight of the tablets after test. 
Hardness:
8
 
Hardness was conducted for 3 tablets from each batch 
using Monsanto hardness tester and average values were 
calculated 
Surface pH Study: 
The bioadhesive tablet was allowed to swell by keeping it 
in contact with 1 mL of distilled water for 2 hrs at room 
temperature. The pH was measured by bringing the pH-
meter electrode, in contact with the surface of the tablet 
and allowing it to equilibrate for 1 min. 
Drug Content:
9
 
Formulation 
code 
Captopril 
(mg) 
HPMC K4M 
(mg) 
Bael gum 
(mg) 
Chitosan 
(mg) 
Lactose 
(mg) 
Talc 
(%) 
Mg. 
stearate 
(%) 
Total 
wt. 
F1 50 200 -------- -------- 50 0.5 0.5 300 
F2 50 100 100 -------- 50 0.5 0.5 300 
F3 50 100 -------- 100 50 0.5 0.5 300 
F4 50 -------- 200 -------- 50 0.5 0.5 300 
F5 50 -------- 100 100 50 0.5 0.5 300 
F6 50 -------- -------- 200 50 0.5 0.5 300 
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Three tablets from each batch were taken in separate 100 
mL volumetric flaks containing 100 mL of pH 7.4 
phosphate buffer and were kept for 24 hrs under constant 
stirring. The solutions were then filtered, diluted suitably 
and analyzed at 212 nm using UV- spectrophotometer. 
The average of three tablets was taken as the content of 
drug in one tablet unit. 
Swelling index:
10 
Swelling of tablet excipients particles involves the 
absorption of a liquid resulting in an increase in weight 
and volume. Liquid uptake by the particle may be due to 
saturation of capillary spaces within the particles or 
hydration of macromolecule. The liquid enters the 
particles through pores and bind to large molecule, 
breaking the hydrogen bond and resulting in the swelling 
of particle. The extent of swelling can be measured in 
terms of %weight gain by the tablet. For each formulation 
batch, one tablet was weighed and placed in a beaker 
containing 200 ml of phosphate buffer media pH 7.4. 
After each interval the tablet was removed from beaker 
and weighed again up to 9 hrs. The swelling index was 
calculated using following formula. 
      Swelling index (S.I.) = (Wt-Wo)/ Wo ×100 
Where, S.I. = Swelling index 
Wt = Weight of tablet at time t 
Wo = Weight of tablet before placing in the beaker 
Wash off test:
7 
The mucoadhesive properties of the tablets were 
evaluated by an in-vitro adhesion testing method known 
as wash off method. Pieces of intestinal mucosa were 
mounted on to glass slides were connected with suitable 
support. About 2 tablets attached on to the slide and the 
support was hung on to the arm of a USP tablet 
disintegrating test machine. By operating the 
disintegrating test machine was given a slow regular up 
and down movement in the test fluid (phosphate buffer 
pH 7.4) at 37°C temperatures. At the time of detachment 
of both tablets was noted down. 
Mucoadhesive strength:
10
 
Mucoadhesive strength of the tablets was measured on 
the modified physical balance. The apparatus consist of a 
modified double beam physical balance in which the right 
pan has been replaced by a glass slide with copper wire 
and additional weight, to make the right side weight equal 
with left side pan. A taflone block of 3.8 cm diameter and 
2 cm height was fabricated with an upward portion of 2 
cm height and 1.5 cm diameter on one side. This was kept 
in beaker filled with phosphate buffer pH 7.4, which was 
then placed below right side of the balance. Goat 
intestinal mucosa was used as a model membrane and 
phosphate buffer pH 7.4 was used as moistening fluid. 
The goat intestinal mucosa was obtained from local 
slaughter house and kept in a Krebs buffer during 
transportation. The underlying mucous membrane was 
separated using surgical blade and wash thoroughly with 
phosphate buffer pH 7.4. It was then tied over the 
protrusion in the teflon block using a thread. The block 
was then kept in glass beaker. The beaker was filled with 
phosphate buffer pH 7.4 up to the upper surface of the 
goat intestinal mucosa to maintain intestinal mucosa 
viability during the experiments. The one side of the 
tablet was attached to the glass slide of the right arm of 
the balance and then the beaker was raised slowly until 
contact between goat intestinal mucosa and 
mucoadhesive tablet was established. A preload of 10 mg 
was placed on the slide for 15 mins (preload time) to 
established adhesion bonding between mucoadhesive 
tablet and goat intestinal mucosa. The preload and 
preload time were kept constant for all formulations. 
After the completion of preload time, preload was 
removed from the glass slide and water was then added in 
the plastic bottle in left side arm by peristaltic pump at a 
constant rate of 100 drops per min. The addition of water 
was stopped when mucoadhesive tablet was detached 
from the goat intestinal mucosa. The weight of water 
required to detach mucoadhesive tablet from goat 
intestinal mucosa was noted as mucoadhesive strength in 
grams. Force of adhesion was calculated from this test by 
using the following formula. 
 
In-vitro drug release studies of enteric coated tablet:
6
 
The release rates of prepared enteric coated 
mucoadhesive tablets of Captopril were studied using the 
(USP II) rotating paddle method under sink conditions at 
37±0.5ºc and 50 rpm. The tablets were placed in the 
basket and tested for drug release for 2 hrs in 0.1(N) HCl 
solution and tested for drug release for 1 hr in pH 6.5 and 
7.8 phosphate buffer solution upto 12 hrs. 
Kinetics of Drug Release:
12
 
Zero order models: 
Drug dissolution from dosage forms that do not 
disaggregate and release the drug slowly can be 
represented by the equation: 
Qt- Q0 = -K0t                   (1) 
Rearrangement of equation (1) yields: 
Qt = Q0 - K0t                     (2) 
Whereas Qt is the amount of drug dissolved in time t, 
Q0 is the initial amount of drug in the solution (most 
times, Q0 = 0) and K0 is the zero order release constant 
expressed in units of concentration/time. 
First order model: 
The release of the drug which followed first order kinetics 
can be expressed by the equation: 
dc/dt= - kc                           (3) 
Where k is first order rate constant expressed in units of 
time-1. 
Equation (3) can be expressed as: 
log C = log C0 - kt / 2.303     (4) 
Where C0 is the initial concentration of drug, k is the first 
order rate constant, and t is the time. The data obtained 
are plotted as log cumulative percentage of drug 
remaining vs. time which would yield a straight line with 
a slope of -k/2.303. 
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Higuchi model: 
The first example of a mathematical model aimed to 
describe drug release from a matrix system was proposed 
by Huguchi in 1961.  
ft = Q = A √D(2C-Cs) Cs t      ………………..(5) 
Where Q is the amount of drug released in time t per unit 
area A, C is the drug initial concentration, Cs is the drug 
solubility in the matrix media and D is the diffusivity of 
the drug molecules (diffusion coefficient) in the matrix 
substance.  
Korsmeyer Peppas model: 
Korsmeyer et al., (1983) derived a simple relationship 
which described drug release from a polymeric system 
equation. To find out the mechanism of drug release, drug 
release data were fitted in Korsmeyer Peppas model. 
Mt / M∞ = Ktn 
Where Mt / M∞ are a fraction of drug released at time t, k 
is the release rate constant and n is the release exponent.  
RESULT AND DISCUSSION: 
Result:
 
Table 3: Evaluation of granules 
 
Table 4: Evaluation of mucoadhesive tablet 
 
Table 5: Wash off test 
 
 
 
Formulation 
code 
Angle of repose 
(
0
) 
Bulk density 
(gm/cm
3
) 
Tapped density 
(gm/cm
3
) 
Carr’s ratio 
(%) 
Hausner’s 
ratio 
Total porosity 
(%) 
F1 22.83 0.51 0.58 12.06 1.13 11.39 
F2 21.29 0.58 0.63 7.93 1.08 8.64 
F3 23.45 0.59 0.64 7.81 1.08 12.50 
F4 20.32 0.51 0.58 12.06 1.13 8.75 
F5 23.41 0.51 0.58 12.06 1.13 13.41 
F6 25.78 0.52 0.59 11.86 1.13 22.22 
Formulation 
code 
Thickness 
(mm) 
Diameter 
(mm) 
Hardness 
(kg/cm
2
) 
Weight 
variation 
(%) 
Friability 
(%) 
Drug 
content 
(%) 
Surface 
pH 
F1 5.4 9.6 6.9 0.020 0.100033 94.347 7.1 
F2 5.5 9.5 6.7 -0.006 0.100167 99.130 7.1 
F3 5.6 9.6 6.4 0.009 0.100127 97.391 7.0 
F4 5.4 9.6 6.5 0.016 0.033344 93.043 6.9 
F5 5.5 9.6 6.5 0.028 0.100033 94.782 7.0 
F6 5.7 9.4 6.6 -0.005 0.100067 97.391 7.1 
Formulation code Sl. No. of tablet Detachment time (mins) Average detachment time  
(mins) 
F1 1 421 416 
 2 411 
F2 1 432 428 
 2 424 
F3 1 372 390 
 2 408 
F4 1 465 452 
 2 439 
F5 1 405 401 
 2 397 
F6 1 376 380 
 2 384 
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Figure 1: Comparative %swelling index of formulation F1 to F6. 
 
Figure 2: Comparative mucoadhesive strength of various formulations. 
 
Figure 3: Comparative force of adhesion of various formulations. 
 
Figure 4: Comparative %cumulative drug release of various formulations. 
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Release kinetics of formulation containing bael gum (F4): 
 
Figure 5: Zero order release kinetics model of enteric coated mucoadhesive tablet containing bael gum (F4) 
 
Figure 6: First order release kinetics model of enteric coated mucoadhesive tablet containing bael gum (F4) 
 
Figure 7: Higuchi model of enteric coated mucoadhesive tablet containing bael gum (F4) 
 
Figure 8: Korsmeyer Peppas model of enteric coated mucoadhesive tablet containing bael gum (F4) 
DISCUSSION: 
Thickness of various formulations F1to F6 was found to be 
in the range of 5.4 mm to 5.7 mm. And diameter of various 
formulations was found in the range of 9.4 mm to 9.6 mm. 
Parameters are shown in table no. 4. 
Hardness of the batches F1to F6 was found to be in the 6.4 
kg/cm2 to 6.9 kg/cm2.  And %weight variation of various 
formulations was found in the range of -0.006 % to 0.020 
%. It seems that weight variation was within the limit. 
Hardness and weight variation of various batches are 
shown in table no. 4. As per the obtained result, it can be 
summarized that the average percentage loss in weight of 
the formulations F1 to F6 was found to be in the range of 
0.033344 % to 0.100127 %. Drug content of formulations 
were in the range of 93.043 % to 99.130 %. In all the 
prepared tablets the specified amount of Captopril were 
found, which indicates the uniformity in drug content 
shown in the table no. 4. The tabulated data shows that the 
surface pH of the formulations F1 to F6 was found to be in 
the range of 6.9 to 7.1. It seems that the surface pH of all 
the formulations was within the satisfactory limit. Surface 
pH of various batches is shown in table no. 4.  
Portrays of the swelling percentage of all the formulations 
(F1 to F6) shown in figure 1. All the formulations were 
showing better swelling properties. The detachment time 
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of formulations was shown in table no. 5. Average 
detachment time of different formulations F1to F6 was in 
the range of 380 mins to 452 mins. And it was suggesting 
that all the formulations have sufficient mucoadhesive 
strength to remain intact with gastric mucosa for long time 
to release the drug in a controlled manner. Detachment 
time of formulations is shown in table no.5. As per the 
obtained result, it can be summarized that the 
mucoadhesive strength of the formulations F1to F6 shows 
adhesion strength in the range of 22.003 gm to 38.003 gm. 
Mucoadhesive strength and force of adhesion of various 
formulations were shown in figure no.2 and 3. 
Formulations F1 to F6 showing release in the range of 
86.488 % to 97.186 %.The formulation F4 containing bael 
gum has shows a better drug release of 86.488 % after 
coating in comparisons to formulations F1to F6 with in 12 
hrs. %Cumulative drug release of F1 to F6 formulations 
was shown in the figure no. 4. 
CONCLUSION: 
Delayed sustained release tablet of Captopril was prepared 
by the wet granulation technique using HPMC K4M, bael 
gum and chitosan as mucoadhesive polymer. It was 
concluded that the rate of drug release from all the 
formulations primarily was good. The coating was done by 
spraying method using eudragit RL100 as a polymer. The 
prepared tablet was found to be successful with respect to 
parameters evaluated such as weight variation, friability, 
drug content, surface pH, wash off test, mucoadhesive 
strength and in-vitro drug release study.  According to 
wash-off test the formulation containing bael gum showing 
better results. According to mucoadhesive strength, F4 
(formulation containing bael gum) showing best result 
among all the formulations.  In in-vitro drug release study 
formulation (F4) containing bael gum showing better 
control release among all the formulations i.e. 86.488 % in 
12 hrs. 
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